Views on diabetes technology sought

Challenges faced by people with diabetes using continuous glucose monitoring (CGM) and hybrid closed-loop systems focus of survey.

A survey designed to highlight the challenges faced by the diabetes community using technology to manage the condition has been extended, allowing more time for people with the condition to share their experiences.

The Living with Diabetes Survey will gather feedback on the use of technology for self-management, including tools such as CGM and hybrid closed-loop systems.

The study was launched by Afon Technology, a Monmouthshire, Wales-based company who developed the world’s first non-invasive blood glucose monitor, to gain deeper insights into the realities of living with the diabetes.

Sabih Chaudhry, CEO of Afon Technology, said: “Understanding the real challenges faced by the diabetes community is crucial to driving meaningful change.

“By extending the survey, we are giving more people the opportunity to share their experiences, ensuring that their voices are heard and that their insights help shape the future of diabetes care, technology, and innovation.”

He added: “The more we learn from those living with the condition, the better equipped we are to develop solutions that truly meet their needs.”

Researchers at the company are pioneering the world’s first non-invasive wearable blood glucose sensor, a breakthrough that could transform diabetes care by completely removing the need for needles in glucose monitoring.

Designed to be worn on the inside of the wrist, the sensor wirelessly transmits real-time blood sugar data via Bluetooth to a companion app. The app provides users with continuous glucose insights, personalised health trends, and instant alerts for high or low levels, offering a seamless and pain-free way to manage diabetes.

Non-invasive blood glucose monitoring has been described as the ‘holy grail’ in the world of diabetes – a mystery that, as yet, has eluded researchers.

The number of adults living with diabetes globally is estimated at 537 million. The NHS spends £10 billion per year on diabetes, with NHS Wales spending £500 million each year on the condition.

Preliminary clinical research gives people with diabetes hope that such a device could become a reality in the near future.

To take part in the survey, click here